Category: Terumo Corp.
InspireMD nets nearly $23 million from a public stock offering, saying it plans to use the proceeds to pursue U.S. approval of its MGuard coronary and carotid stents.
InspireMD (OTC:NSPR) said it added some $23 million to its coffers in a public stock offering.
The Tel Aviv-based medical device company makes the MGuard device, designed to protect against embolism after stenting procedures.
It was a big week for medical device company Medtronic's Symplicity renal denervation device for treating high blood pressure, with the release of new clinical data and a pair of regulatory developments for the device.
It was a big week for Medtronic (NYSE:MDT) and its Symplicity high blood pressure device, with the release of 2-year clinical data and a pair of regulatory developments for the renal denervation system.
Japanese medical device company Terumo says it's spiking a distribution deal with Boston Scientific for its GlideWire urological catheter guidewire.
On the heels of gaping losses and a more than 25% sales decline, Accuray announces plans for a $75 million debt round.
Accuray (NSDQ:ARAY) plans to issue $75 million worth of convertible senior notes as it gears up to restructure its business after a year of widening losses.
The Sunnyvale, Calif.-based medical device company said it will use the proceeds from the offering of debt due Feb. 1, 2018, to shore up its balance sheet.
Hospital group purchasing organization Novation awards new contracts for cardiovascular products to a clutch of market leaders.
Group purchasing organization Novation awarded new cardiovascular contracts to a host of market leaders, effective at the beginning of 2013.
Japan's Terumo Corp. proposes a merger with Olympus Corp., aiming for a buyout to block rival companies' advances.
Asian medical device giant Terumo Corp. (TYO:4543) confirmed rumors of a proposed buyout of Olympus (PINK:OCPNY) in the aftermath of a $1.7 billion accounting scandal.
Terumo warns users of false alarms in its heart-lung machines, which could result in disruptions to arterial blood flow or air bubble entrainment in the system.
Terumo Corp. (TYO:4543) warned users of its Advanced Perfusion System 1, Sarns Modular Perfusion System 8000 and Sarns Perfusion System 9000 of possible malfunctions related to the devices' air bubble detections systems.
The company has received "multiple reports" of false alarms generated by the air bubble warning system, although it's a "highly unlikely" malfunction.